The genetics of human autoimmune disease

Journal of Autoimmunity

Volumn 33, Issue 3-4, 2009, Pages 290-299

  Invernizzi, Pietro ^a,b   Gershwin, M Eric ^b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Etiopathogenesis; Female preponderance; Genetic factors; Genome wide association study; Sex chromosome

Indexed keywords

CELL SURFACE RECEPTOR; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 23 RECEPTOR; STAT4 PROTEIN;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; AUTOPHAGY; DISEASE COURSE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LINKAGE ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SEX CHROMOSOME; SINGLE NUCLEOTIDE POLYMORPHISM; X CHROMOSOME LINKED DISORDER;

AUTOIMMUNE DISEASES; AUTOPHAGY; B-LYMPHOCYTES; CYTOKINES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMORPHISM, GENETIC; RECEPTORS, CELL SURFACE; SEX CHROMOSOMES; TRANSCRIPTION FACTORS;

EID: 71649102108     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.07.008     Document Type: Article

References (188)

1. Davies A.J. Immunological tolerance and the autoimmune response. Autoimmun Rev 7 (2008) 538-543
2. Lleo A., Battezzati P.M., Selmi C., Gershwin M.E., and Podda M. Is autoimmunity a matter of sex?. Autoimmun Rev 7 (2008) 626-630
3. Boscolo P., Youinou P., Theoharides T.C., Cerulli G., and Conti P. Environmental and occupational stress and autoimmunity. Autoimmun Rev 7 (2008) 340-343
4. Morahan G., Peeva V., Mehta M., and Williams R. Systems genetics can provide new insights in to immune regulation and autoimmunity. J Autoimmun 31 (2008) 233-236
5. Jacobson E.M., Huber A., and Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 30 (2008) 58-62
6. McCluskey J., and Peh C.A. The human leucocyte antigens and clinical medicine: an overview. Rev Immunogenet 1 (1999) 3-20
7. Etzensperger R., McMahon R.M., Jones E.Y., and Fugger L. Dissection of the multiple sclerosis associated DR2 haplotype. J Autoimmun 31 (2008) 201-207
8. Baschal E.E., and Eisenbarth G.S. Extreme genetic risk for type 1A diabetes in the post-genome era. J Autoimmun 31 (2008) 1-6
9. Jacobson E.M., and Tomer Y. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J Autoimmun 28 (2007) 85-98
10. Castro J., Balada E., Ordi-Ros J., and Vilardell-Tarres M. The complex immunogenetic basis of systemic lupus erythematosus. Autoimmun Rev 7 (2008) 345-351
11. Invernizzi P., Pasini S., Selmi C., Gershwin M.E., and Podda M. Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun 33 (2009) 12-16
12. Fathman C.G., Soares L., Chan S.M., and Utz P.J. An array of possibilities for the study of autoimmunity. Nature 435 (2005) 605-611
13. Hardy J., and Singleton A. Genomewide association studies and human disease. N Engl J Med 360 (2009) 1759-1768
14. Lettre G., and Rioux J.D. Autoimmune diseases: insights from genome-wide association studies. Hum Molecular Genetics 17 (2008) R116-R121
15. Schaschl H., Aitman T.J., and Vyse T.J. Copy number variation in the human genome and its implication in autoimmunity. Clin Exp Immunol 156 (2009) 12-16
16. Fernando M.M., Stevens C.R., Walsh E.C., De Jager P.L., Goyette P., Plenge R.M., et al. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genetics 4 (2008) e1000024
17. Daly A.K. Candidate gene case-control studies. Pharmacogenomics 4 (2003) 127-139
18. Ioannidis J.P., Ntzani E.E., Trikalinos T.A., and Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat Genet 29 (2001) 306-309
19. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., Hom G., Behrens T.W., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 357 (2007) 977-986
20. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
21. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
22. McCarthy M.I., Abecasis G.R., Cardon L.R., Goldstein D.B., Little J., Ioannidis J.P., et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9 (2008) 356-369
23. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., et al. The sequence of the human genome. Science 291 (2001) 1304-1351
24. Carlson C.S., Eberle M.A., Rieder M.J., Smith J.D., Kruglyak L., and Nickerson D.A. Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans. Nat Genet 33 (2003) 518-521
25. Carmona L., Villaverde V., Hernandez-Garcia C., Ballina J., Gabriel R., and Laffon A. The prevalence of rheumatoid arthritis in the general population of Spain. Rheumatol (Oxford) 41 (2002) 88-95
26. Dawson E., Abecasis G.R., Bumpstead S., Chen Y., Hunt S., Beare D.M., et al. A first-generation linkage disequilibrium map of human chromosome 22. Nature 418 (2002) 544-548
27. Patil N., Berno A.J., Hinds D.A., Barrett W.A., Doshi J.M., Hacker C.R., et al. Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 294 (2001) 1719-1723
28. Abecasis G.R., Noguchi E., Heinzmann A., Traherne J.A., Bhattacharyya S., Leaves N.I., et al. Extent and distribution of linkage disequilibrium in three genomic regions. Am J Hum Genet 68 (2001) 191-197
29. The International HapMap project. Nature 426 (2003) 789-796
30. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678
31. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314 (2006) 1461-1463
32. Hampe J., Franke A., Rosenstiel P., Till A., Teuber M., Huse K., et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39 (2007) 207-211
33. Libioulle C., Louis E., Hansoul S., Sandor C., Farnir F., Franchimont D., et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genetics 3 (2007) e58
34. Rioux J.D., Xavier R.J., Taylor K.D., Silverberg M.S., Goyette P., Huett A., et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39 (2007) 596-604
35. Parkes M., Barrett J.C., Prescott N.J., Tremelling M., Anderson C.A., Fisher S.A., et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 39 (2007) 830-832
36. Barrett J.C., Hansoul S., Nicolae D.L., Cho J.H., Duerr R.H., Rioux J.D., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40 (2008) 955-962
37. Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., Gibbs R.A., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449 (2007) 851-861
38. Husain Z., Kelly M.A., Eisenbarth G.S., Pugliese A., Awdeh Z.L., Larsen C.E., et al. The MHC type 1 diabetes susceptibility gene is centromeric to HLA-DQB1. J Autoimmun 30 (2008) 266-272
39. Gebe J.A., Unrath K.A., Yue B.B., Miyake T., Falk B.A., and Nepom G.T. Autoreactive human T-cell receptor initiates insulitis and impaired glucose tolerance in HLA DR4 transgenic mice. J Autoimmun 30 (2008) 197-206
40. Carson D.A. Genetic factors in the etiology and pathogenesis of autoimmunity. FASEB J 6 (1992) 2800-2805
41. Horton R., Wilming L., Rand V., Lovering R.C., Bruford E.A., Khodiyar V.K., et al. Gene map of the extended human MHC. Nat Rev Genet 5 (2004) 889-899
42. Chao M.J., Barnardo M.C., Lincoln M.R., Ramagopalan S.V., Herrera B.M., Dyment D.A., et al. HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility. Proc Natl Acad Sci U S A 105 (2008) 13069-13074
43. Ding B., Padyukov L., Lundstrom E., Seielstad M., Plenge R.M., Oksenberg J.R., et al. Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region. Arthritis Rheum 60 (2009) 30-38
44. Lee H.S., Lee A.T., Criswell L.A., Seldin M.F., Amos C.I., Carulli J.P., et al. Several regions in the major histocompatibility complex confer risk for anti-CCP-antibody positive rheumatoid arthritis, independent of the DRB1 locus. Mol Med 14 (2008) 293-300
45. Hirschfield G.M., Liu X., Xu C., Lu Y., Xie G., Lu Y., et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 360 (2009) 2544-2555
46. Nejentsev S., Howson J.M., Walker N.M., Szeszko J., Field S.F., Stevens H.E., et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450 (2007) 887-892
47. Li H.S., Ligons D.L., and Rose N.R. Genetic complexity of autoimmune myocarditis. Autoimmun Rev 7 (2008) 168-173
48. Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., Rostamkhani M., et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 36 (2004) 337-338
49. Begovich A.B., Carlton V.E., Honigberg L.A., Schrodi S.J., Chokkalingam A.P., Alexander H.C., et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75 (2004) 330-337
50. Kyogoku C., Langefeld C.D., Ortmann W.A., Lee A., Selby S., Carlton V.E., et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 75 (2004) 504-507
51. Nath S.K., Han S., Kim-Howard X., Kelly J.A., Viswanathan P., Gilkeson G.S., et al. A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat Genet 40 (2008) 152-154
52. Laurin N., Feng Y., Ickowicz A., Pathare T., Malone M., Tannock R., et al. No preferential transmission of paternal alleles at risk genes in attention-deficit hyperactivity disorder. Mol Psychiatry 12 (2007) 226-229
53. Duerr R.H. Genome-wide association studies herald a new era of rapid discoveries in inflammatory bowel disease research. Gastroenterology 132 (2007) 2045-2049
54. Cargill M., Schrodi S.J., Chang M., Garcia V.E., Brandon R., Callis K.P., et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80 (2007) 273-290
55. Stranger B.E., Nica A.C., Forrest M.S., Dimas A., Bird C.P., Beazley C., et al. Population genomics of human gene expression. Nat Genet 39 (2007) 1217-1224
56. Myers A.J., Gibbs J.R., Webster J.A., Rohrer K., Zhao A., Marlowe L., et al. A survey of genetic human cortical gene expression. Nat Genet 39 (2007) 1494-1499
57. Emilsson V., Thorleifsson G., Zhang B., Leonardson A.S., Zink F., Zhu J., et al. Genetics of gene expression and its effect on disease. Nature 452 (2008) 423-428
58. Duan S., Huang R.S., Zhang W., Bleibel W.K., Roe C.A., Clark T.A., et al. Genetic architecture of transcript-level variation in humans. Am J Hum Genet 82 (2008) 1101-1113
59. Kwan T., Benovoy D., Dias C., Gurd S., Provencher C., Beaulieu P., et al. Genome-wide analysis of transcript isoform variation in humans. Nat Genet 40 (2008) 225-231
60. Schadt E.E., Molony C., Chudin E., Hao K., Yang X., Lum P.Y., et al. Mapping the genetic architecture of gene expression in human Liver. PLoS Biol 6 (2008) e107
61. Kwan T., Benovoy D., Dias C., Gurd S., Serre D., Zuzan H., et al. Heritability of alternative splicing in the human genome. Genome Res 17 (2007) 1210-1218
62. Vella A., Cooper J.D., Lowe C.E., Walker N., Nutland S., Widmer B., et al. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet 76 (2005) 773-779
63. Hunt K.A., Zhernakova A., Turner G., Heap G.A., Franke L., Bruinenberg M., et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 40 (2008) 395-402
64. van Heel D.A., Franke L., Hunt K.A., Gwilliam R., Zhernakova A., Inouye M., et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 39 (2007) 827-829
65. Zhernakova A., Alizadeh B.Z., Bevova M., van Leeuwen M.A., Coenen M.J., Franke B., et al. Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases. Am J Hum Genet 81 (2007) 1284-1288
66. Hafler D.A., Compston A., Sawcer S., Lander E.S., Daly M.J., De Jager P.L., et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357 (2007) 851-862
67. Gregory S.G., Schmidt S., Seth P., Oksenberg J.R., Hart J., Prokop A., et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 39 (2007) 1083-1091
68. Rubio J.P., Stankovich J., Field J., Tubridy N., Marriott M., Chapman C., et al. Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians. Genes Immun 9 (2008) 624-630
69. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 41 (2009) 824-828
70. Lowe C.E., Cooper J.D., Brusko T., Walker N.M., Smyth D.J., Bailey R., et al. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat Genet 39 (2007) 1074-1082
71. Crispin J.C., and Tsokos G.C. Transcriptional regulation of IL-2 in health and autoimmunity. Autoimmun Rev 8 (2009) 190-195
72. Todd J.A., Walker N.M., Cooper J.D., Smyth D.J., Downes K., Plagnol V., et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39 (2007) 857-864
73. Fuss I.J., Becker C., Yang Z., Groden C., Hornung R.L., Heller F., et al. Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody. Inflamm Bowel Diseases 12 (2006) 9-15
74. Papp K.A., Langley R.G., Lebwohl M., Krueger G.G., Szapary P., Yeilding N., et al. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2). Lancet 371 (2008) 1675-1684
75. Cho J.H. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Reviews 8 (2008) 458-466
76. Chan J.R., Blumenschein W., Murphy E., Diveu C., Wiekowski M., Abbondanzo S., et al. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J Exp Med 203 (2006) 2577-2587
77. Fry T.J., and Mackall C.L. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immunol 174 (2005) 6571-6576
78. Tozzoli R. Recent advances in diagnostic technologies and their impact in autoimmune diseases. Autoimmun Rev 6 (2007) 334-340
79. Reveille J.D. The genetic basis of autoantibody production. Autoimmun Rev 5 (2006) 389-398
80. Kozyrev S.V., Abelson A.K., Wojcik J., Zaghlool A., Linga Reddy M.V., Sanchez E., et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 40 (2008) 211-216
81. Hom G., Graham R.R., Modrek B., Taylor K.E., Ortmann W., Garnier S., et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 358 (2008) 900-909
82. Guo L., Deshmukh H., Lu R., Vidal G.S., Kelly J.A., Kaufman K.M., et al. Replication of the BANK1 genetic association with systemic lupus erythematosus in a European-derived population. Gene Immun (2009)
83. Chang Y.K., Yang W., Zhao M., Mok C.C., Chan T.M., Wong R.W., et al. Association of BANK1 and TNFSF4 with systemic lupus erythematosus in Hong Kong Chinese. Gene Immun (2009)
84. Ito I., Kawasaki A., Ito S., Hayashi T., Goto D., Matsumoto I., et al. Replication of the association between the C8orf13-BLK region and systemic lupus erythematosus in a Japanese population. Arthritis Rheum 60 (2009) 553-558
85. Yokoyama K., Su Ih I.H., Tezuka T., Yasuda T., Mikoshiba K., Tarakhovsky A., et al. BANK regulates BCR-induced calcium mobilization by promoting tyrosine phosphorylation of IP(3) receptor. EMBO J 21 (2002) 83-92
86. Aiba Y., Yamazaki T., Okada T., Gotoh K., Sanjo H., Ogata M., et al. BANK negatively regulates Akt activation and subsequent B cell responses. Immunity 24 (2006) 259-268
87. Criswell L.A., Pfeiffer K.A., Lum R.F., Gonzales B., Novitzke J., Kern M., et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 76 (2005) 561-571
88. Musone S.L., Taylor K.E., Lu T.T., Nititham J., Ferreira R.C., Ortmann W., et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet 40 (2008) 1062-1064
89. Graham R.R., Cotsapas C., Davies L., Hackett R., Lessard C.J., Leon J.M., et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 40 (2008) 1059-1061
90. Plenge R.M., Padyukov L., Remmers E.F., Purcell S., Lee A.T., Karlson E.W., et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 77 (2005) 1044-1060
91. Gregersen P.K., Amos C.I., Lee A.T., Lu Y., Remmers E.F., Kastner D.L., et al. REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat Genet 41 (2009) 820-823
92. Plenge R.M., Cotsapas C., Davies L., Price A.L., de Bakker P.I., Maller J., et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 39 (2007) 1477-1482
93. Kurreeman F.A., Padyukov L., Marques R.B., Schrodi S.J., Seddighzadeh M., Stoeken-Rijsbergen G., et al. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med 4 (2007) e278
94. De Jager P.L., Jia X., Wang J., de Bakker P.I., Ottoboni L., Aggarwal N.T., et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 41 (2009) 776-782
95. Graham R.R., Kozyrev S.V., Baechler E.C., Reddy M.V., Plenge R.M., Bauer J.W., et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 38 (2006) 550-555
96. Smyth D.J., Cooper J.D., Bailey R., Field S., Burren O., Smink L.J., et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 38 (2006) 617-619
97. Gregersen P.K., and Olsson L.M. Recent advances in the genetics of autoimmune disease. Annu review Immunol 27 (2009) 363-391
98. Hasegawa K., Martin F., Huang G., Tumas D., Diehl L., and Chan A.C. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 303 (2004) 685-689
99. Aarnisalo J., Treszl A., Svec P., Marttila J., Oling V., Simell O., et al. Reduced CD4+T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant. J Autoimmun 31 (2008) 13-21
100. Weersma R.K., Stokkers P.C., Cleynen I., Wolfkamp S.C., Henckaerts L., Schreiber S., et al. Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort. Am J Gastroenterol 104 (2009) 630-638
101. Pao L.I., Badour K., Siminovitch K.A., and Neel B.G. Nonreceptor protein-tyrosine phosphatases in immune cell signaling. Annu Rev Immunol 25 (2007) 473-523
102. Mackay I.R. The "Autoimmune diseases" 40th anniversary. Autoimmun Rev 1 (2002) 5-11
103. Tomer Y., and Huber A. The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun 32 (2009) 231-239
104. Pai S., and Thomas R. Immune deficiency or hyperactivity-Nf-kappab illuminates autoimmunity. J Autoimmun 31 (2008) 245-251
105. Lleo A., Invernizzi P., Selmi C., Coppel R.L., Alpini G., Podda M., et al. Autophagy: highlighting a novel player in the autoimmunity scenario. J Autoimmun 29 (2007) 61-68
106. Sanchez-Pernaute O., Ospelt C., Neidhart M., and Gay S. Epigenetic clues to rheumatoid arthritis. J Autoimmun 30 (2008) 12-20
107. Taylor K.E., Remmers E.F., Lee A.T., Ortmann W.A., Plenge R.M., Tian C., et al. Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus. PLoS Genetics 4 (2008) e1000084
108. Sigurdsson S., Nordmark G., Goring H.H., Lindroos K., Wiman A.C., Sturfelt G., et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 76 (2005) 528-537
109. Graham R.R., Kyogoku C., Sigurdsson S., Vlasova I.A., Davies L.R., Baechler E.C., et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A 104 (2007) 6758-6763
110. Papadimitraki E.D., Bertsias G.K., and Boumpas D.T. Toll like receptors and autoimmunity: a critical appraisal. J Autoimmun 29 (2007) 310-318
111. Niewold T.B., Kelly J.A., Flesch M.H., Espinoza L.R., Harley J.B., and Crow M.K. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Arthritis Rheum 58 (2008) 2481-2487
112. Lee H.S., Remmers E.F., Le J.M., Kastner D.L., Bae S.C., and Gregersen P.K. Association of STAT4 with rheumatoid arthritis in the Korean population. Mol Med 13 (2007) 455-460
113. Kobayashi S., Ikari K., Kaneko H., Kochi Y., Yamamoto K., Shimane K., et al. Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population. Arthritis Rheum 58 (2008) 1940-1946
114. Namjou B., Sestak A.L., Armstrong D.L., Zidovetzki R., Kelly J.A., Jacob N., et al. High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Arthritis Rheum 60 (2009) 1085-1095
115. Harley J.B., Alarcon-Riquelme M.E., Criswell L.A., Jacob C.O., Kimberly R.P., Moser K.L., et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40 (2008) 204-210
116. Hildner K.M., Schirmacher P., Atreya I., Dittmayer M., Bartsch B., Galle P.R., et al. Targeting of the transcription factor STAT4 by antisense phosphorothioate oligonucleotides suppresses collagen-induced arthritis. J Immunol 178 (2007) 3427-3436
117. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423 (2003) 506-511
118. Scalapino K.J., and Daikh D.I. CTLA-4: a key regulatory point in the control of autoimmune disease. Immunol Rev 223 (2008) 143-155
119. Bashyam H. CTLA-4: from conflict to clinic. J Exp Med 204 (2007) 1243
120. Fiocco U., Sfriso P., Oliviero F., Pagnin E., Scagliori E., Campana C., et al. Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept. Autoimmun Rev 8 (2008) 76-82
121. Kremer J.M., Westhovens R., Leon M., Di Giorgio E., Alten R., Steinfeld S., et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med 349 (2003) 1907-1915
122. Invernizzi P., Miozzo M., Battezzati P.M., Bianchi I., Grati F.R., Simoni G., et al. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 363 (2004) 533-535
123. Invernizzi P. Future directions in genetic for autoimmune diseases. J Autoimmun 33 (2009) 1-2
124. Marodi L., and Notarangelo L.D. Immunological and genetic bases of new primary immunodeficiencies. Nat Reviews 7 (2007) 851-861
125. Davis C.J., Davison R.M., Payne N.N., Rodeck C.H., and Conway G.S. Female sex preponderance for idiopathic familial premature ovarian failure suggests an X chromosome defect: opinion. Hum Reprod 15 (2000) 2418-2422
126. Ranke M.B., and Saenger P. Turner's syndrome. Lancet 358 (2001) 309-314
127. Whitacre C.C. Sex differences in autoimmune disease. Nat Immunol 2 (2001) 777-780
128. Gleicher N., and Barad D.H. Gender as risk factor for autoimmune diseases. J Autoimmun 28 (2007) 1-6
129. Zandman-Goddard G., Peeva E., and Shoenfeld Y. Gender and autoimmunity. Autoimmun Rev 6 (2007) 366-372
130. Smith-Bouvier D.L., Divekar A.A., Sasidhar M., Du S., Tiwari-Woodruff S.K., King J.K., et al. A role for sex chromosome complement in the female bias in autoimmune disease. J Exp Med 205 (2008) 1099-1108
131. Hernandez-Molina G., Svyryd Y., Sanchez-Guerrero J., and Mutchinick O.M. The role of the X chromosome in immunity and autoimmunity. Autoimmun Rev 6 (2007) 218-222
132. Invernizzi P., Miozzo M., Oertelt-Prigione S., Meroni P.L., Persani L., Selmi C., et al. X monosomy in female systemic lupus erythematosus. Ann N Y Acad Sci 1110 (2007) 84-91
133. Invernizzi P., Miozzo M., Selmi C., Persani L., Battezzati P.M., Zuin M., et al. X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol 175 (2005) 575-578
134. Scofield R.H., Bruner G.R., Namjou B., Kimberly R.P., Ramsey-Goldman R., Petri M., et al. Klinefelter's syndrome (47, XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum 58 (2008) 2511-2517
135. Brown C.J., and Robinson W.P. The causes and consequences of random and non-random X chromosome inactivation in humans. Clin Genet 58 (2000) 353-363
136. Sharp A., Robinson D., and Jacobs P. Age- and tissue-specific variation of X chromosome inactivation ratios in normal women. Hum Genet 107 (2000) 343-349
137. Chagnon P., Provost S., Belisle C., Bolduc V., Gingras M., and Busque L. Age-associated skewing of X-inactivation ratios of blood cells in normal females: a candidate-gene analysis approach. Exp Hematol 33 (2005) 1209-1214
138. Carrel L., and Willard H.F. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434 (2005) 400-404
139. Invernizzi P., Pasini S., Selmi C., Miozzo M., and Podda M. Skewing of X chromosome inactivation in autoimmunity. Autoimmunity 41 (2008) 272-277
140. Huang Q., Parfitt A., Grennan D.M., and Manolios N. X-chromosome inactivation in monozygotic twins with systemic lupus erythematosus. Autoimmunity 26 (1997) 85-93
141. Chitnis S., Monteiro J., Glass D., Apatoff B., Salmon J., Concannon P., et al. The role of X-chromosome inactivation in female predisposition to autoimmunity. Arthritis Res 2 (2000) 399-406
142. Knudsen G.P., Harbo H.F., Smestad C., Celius E.G., Akesson E., Oturai A., et al. X chromosome inactivation in females with multiple sclerosis. Eur J Neurol 14 (2007) 1392-1396
143. Miozzo M., Selmi C., Gentilin B., Grati F.R., Sirchia S., Oertelt S., et al. Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis. Hepatol (Baltimore MD) 46 (2007) 456-462
144. Ozcelik T., Uz E., Akyerli C.B., Bagislar S., Mustafa C.A., Gursoy A., et al. Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity. Eur J Hum Genet 14 (2006) 791-797
145. Ozbalkan Z., Bagislar S., Kiraz S., Akyerli C.B., Ozer H.T., Yavuz S., et al. Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum 52 (2005) 1564-1570
146. Brix T.H., Knudsen G.P., Kristiansen M., Kyvik K.O., Orstavik K.H., and Hegedus L. High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity. J Clin Endocrinol Metabolism 90 (2005) 5949-5953
147. Yin X., Latif R., Tomer Y., and Davies T.F. Thyroid epigenetics: X chromosome inactivation in patients with autoimmune thyroid disease. Ann New Y Acad Sci 1110 (2007) 193-200
148. Ozcelik T. X chromosome inactivation and female predisposition to autoimmunity. Clin Rev Allergy Immunol 34 (2008) 348-351
149. Pessach I.M., and Notarangelo L.D. X-linked primary immunodeficiencies as a bridge to better understanding X-chromosome related autoimmunity. J Autoimmun 33 (2009) 17-24
150. Larizza D., Calcaterra V., and Martinetti M. Autoimmune stigmata in Turner syndrome: when lacks an X chromosome. J Autoimmun 33 (2009) 25-30
151. Persani L., Rossetti R., Cacciatore C., and Bonomi M. Primary Ovarian Insufficiency: X chromosome defects and autoimmunity. J Autoimmun 33 (2009) 35-41
152. Sawalha A.H., Harley J.B., and Scofield R.H. Autoimmunity and Klinefelter's syndrome: when men have two X chromosomes. J Autoimmun 33 (2009) 31-34
153. Hewagama A., and Richardson B. The genetics and epigenetics of autoimmune diseases. J Autoimmun 33 (2009) 3-11
154. Henrichsen C.N., Chaignat E., and Reymond A. Copy number variants, diseases and gene expression. Hum Mol Genet 18 (2009) R1-R8
155. Redon R., Ishikawa S., Fitch K.R., Feuk L., Perry G.H., Andrews T.D., et al. Global variation in copy number in the human genome. Nature 444 (2006) 444-454
156. Fanciulli M., Norsworthy P.J., Petretto E., Dong R., Harper L., Kamesh L., et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet 39 (2007) 721-723
157. Aitman T.J., Dong R., Vyse T.J., Norsworthy P.J., Johnson M.D., Smith J., et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 439 (2006) 851-855
158. Willcocks L.C., Lyons P.A., Clatworthy M.R., Robinson J.I., Yang W., Newland S.A., et al. Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med 205 (2008) 1573-1582
159. Yang Y., Chung E.K., Wu Y.L., Savelli S.L., Nagaraja H.N., Zhou B., et al. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet 80 (2007) 1037-1054
160. Mamtani M., Rovin B., Brey R., Camargo J.F., Kulkarni H., Herrera M., et al. CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus. Ann Rheum Dis 67 (2008) 1076-1083
161. Breunis W.B., van Mirre E., Bruin M., Geissler J., de Boer M., Peters M., et al. Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura. Blood 111 (2008) 1029-1038
162. Hollox E.J., Huffmeier U., Zeeuwen P.L., Palla R., Lascorz J., Rodijk-Olthuis D., et al. Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 40 (2008) 23-25
163. Fellermann K., Stange D.E., Schaeffeler E., Schmalzl H., Wehkamp J., Bevins C.L., et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 79 (2006) 439-448
164. McKinney C., Merriman M.E., Chapman P.T., Gow P.J., Harrison A.A., Highton J., et al. Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis. Ann Rheum Dis 67 (2008) 409-413
165. Lee-Kirsch M.A., Gong M., Chowdhury D., Senenko L., Engel K., Lee Y.A., et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 39 (2007) 1065-1067
166. Pritchard J.K. Are rare variants responsible for susceptibility to complex diseases?. Am J Hum Genet 69 (2001) 124-137
167. Fearnhead N.S., Wilding J.L., Winney B., Tonks S., Bartlett S., Bicknell D.C., et al. Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc Natl Acad Sci U S A 101 (2004) 15992-15997
168. Cohen J.C., Kiss R.S., Pertsemlidis A., Marcel Y.L., McPherson R., and Hobbs H.H. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305 (2004) 869-872
169. Ozawa K., Sato K., Oh I., Ozaki K., Uchibori R., Obara Y., et al. Cell and gene therapy using mesenchymal stem cells (MSCs). J Autoimmun 30 (2008) 121-127
170. Shoenfeld Y., Selmi C., Zimlichman E., and Gershwin M.E. The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 31 (2008) 325-330
171. Whittingham S., Rowley M.J., and Gershwin M.E. A tribute to an outstanding immunologist - Ian Reay Mackay. J Autoimmun 31 (2008) 197-200
172. Gershwin M.E. Bone marrow transplantation, refractory autoimmunity and the contributions of Susumu Ikehara. J Autoimmun 30 (2008) 105-107
173. Blank M., and Gershwin M.E. Autoimmunity: from the mosaic to the kaleidoscope. J Autoimmun 30 (2008) 1-4
174. Burton P.R., Clayton D.G., Cardon L.R., Craddock N., Deloukas P., Duncanson A., et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 39 (2007) 1329-1337
175. Suzuki A., Yamada R., Chang X., Tokuhiro S., Sawada T., Suzuki M., et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 34 (2003) 395-402
176. Thomson W., Barton A., Ke X., Eyre S., Hinks A., Bowes J., et al. Rheumatoid arthritis association at 6q23. Nat Genet 39 (2007) 1431-1433
177. Plenge R.M., Seielstad M., Padyukov L., Lee A.T., Remmers E.F., Ding B., et al. TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. New Engl Journal Medicine 357 (2007) 1199-1209
178. Raychaudhuri S., Remmers E.F., Lee A.T., Hackett R., Guiducci C., Burtt N.P., et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 40 (2008) 1216-1223
179. Vafiadis P., Bennett S.T., Todd J.A., Nadeau J., Grabs R., Goodyer C.G., et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 15 (1997) 289-292
180. Pugliese A., Zeller M., Fernandez Jr. A., Zalcberg L.J., Bartlett R.J., Ricordi C., et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 15 (1997) 293-297
181. Powell B.R., Buist N.R., and Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 100 (1982) 731-737
182. Chatila T.A., Blaeser F., Ho N., Lederman H.M., Voulgaropoulos C., Helms C., et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 106 (2000) R75-R81
183. Sullivan K.E., Mullen C.A., Blaese R.M., and Winkelstein J.A. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 125 (1994) 876-885
184. Conley M.E., and Howard V. Clinical findings leading to the diagnosis of X-linked agammaglobulinemia. J Pediatr 141 (2002) 566-571
185. Levy J., Espanol-Boren T., Thomas C., Fischer A., Tovo P., Bordigoni P., et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 131 (1997) 47-54
186. Zonana J., Elder M.E., Schneider L.C., Orlow S.J., Moss C., Golabi M., et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet 67 (2000) 1555-1562
187. Cale C.M., Morton L., and Goldblatt D. Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology. Clin Exp Immunol 148 (2007) 79-84
188. Moretta A., Bottino C., Parolini S., Moretta L., Biassoni R., and Notarangelo L.D. Cellular and molecular pathogenesis of X-linked lymphoproliferative disease. Curr Opin Allergy Clin Immunol 1 (2001) 513-517